ISRN Dentistry

Volume 2014 (2014), Article ID 479187, 4 pages

http://dx.doi.org/10.1155/2014/479187

Research Article

Silver Binding Nucleolar Organizer Regions Dots in Oral Leukoplakia with Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An In Vivo Study

Fahad Mansoor Samadi,¹ Bastain Thattil Sebastian,² Anil Singh,³ Shaleen Chandra,¹ Shadab Mohammad,⁴ Arun Singh,⁵ Thippeswamy Halappa,⁶ and Firoza Samadi⁷

¹Department of Oral Pathology & Microbiology, King George's Medical University, Lucknow, India

²Department of Oral Pathology & Microbiology, Mahe Institute of Dental Sciences, Palloor, Mahe, Puducherry, India

³Department of Oral Pathology & Microbiology, Saraswati Dental College, Lucknow, India

⁴Department of Oral & Maxillofacial Surgery, King George's Medical University, Lucknow, India

⁵Department of Oral Pathology & Microbiology, Kothiwal Dental College & Research Centre, Moradabad, Uttar Pradesh, India

⁶Department of Oral Pathology & Microbiology, Babu Banarsi Das College of Dental Sciences, Lucknow, India

⁷Department of Pedodontics, Career Post Graduate Institute of Dental Sciences and Hospital, Lucknow, Uttar Pradesh, India

Received 5 December 2013; Accepted 25 December 2013; Published 30 April 2014

Academic Editors: M. Okura and D. Wray

Copyright © 2014 Fahad Mansoor Samadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Silver binding nucleolar organizer regions (AgNOR) in normal oral mucosa (NOM), oral leukoplakia with epithelial dysplasia (ED), and oral squamous cell carcinoma (OSCC) were studied. The mean AgNOR count per nucleus increased from NOM to ED to OSCC. Tissue showing ED in oral leukoplakia and OSCC cases showed higher counts, wider scatter, and smaller size of AgNOR dots in the nuclei. The study seems to suggest that time method has some potential in distinguishing between NOM and oral leukoplakia with ED and OSCC. Studies of larger numbers are needed to arrive at more substantial conclusions.

1. Introduction

Leukoplakias are group of lesions of different etiologies and most common potentially malignant oral lesions. Epithelial dysplasias (ED) are malignant changes, seen in leukoplakias [1]. Oral squamous cell carcinoma (OSCC) is a malignant neoplasm arising from mucosal epithelium. Its early detection is crucial. To date, no clear markers have evolved to distinguish them [2]. Patterns of nucleolar organizer regions (NOR) as visualized by silver staining (AgNOR) vary with different cell cycle stages. These are replicatory markers useful in diagnosing oral leukoplakia [3].

The purpose of this study was to quantify AgNOR count in tissue sections of normal oral mucosa (NOM), ED, and OSCC.

2. Materials and Method

The study consisted of three groups divided into Group I (control group, ten cases of NOM), Group II (30 cases of ED—ten each of mild, moderate, and severe cases), and Group III (30 cases of OSCC—ten each of well differentiated, moderately differentiated, and poorly differentiated).

Two histological sections of five μm thickness were obtained from each case. One section was stained with hematoxylin and eosin (H&E) stain and the other with silver nitrate solution. AgNOR staining was done according to modified procedure of Smith and Crocker [4]. After the histological grading of the lesions with H&E sections, corresponding silver stained sections were subjected to quantitative analysis of AgNOR dots and carried out under X100 oil immersion lens.

In each section, five different fields with the most representative areas were selected, which included five largest nuclei with clear outline in each field.

The numbers of silver stained, black dots were counted in each nucleus. AgNOR dots seen in a clump were counted as single AgNOR dot. Further mean AgNOR count in each case was determined and tabulated and subjected to statistical analysis.

3. Results

Table 1 shows the mean AgNOR count in different study groups.

Table 1: Mean AgNOR count and standard deviation in different study groups.

Study groups
Mean ± S.D.

NOM
2.572 ± 0.121

Mild ED
5.184 ± 0.095

Moderate ED
5.628 ± 0.477

Severe ED
5.993 ± 0.262

Well differentiated OSCC
7.351 ± 0.285

Moderately differentiated OSCC
8.060 ± 0.175

Poorly differentiated OSCC
8.810 ± 0.302

Table 2 shows the analysis of variance of mean AgNOR count in different study groups.

Table 2: Analysis of variance of mean AgNOR count in different study groups.

Sum of squares
Df
Mean square

Between study groups
258.624
6
43.104
724.530

Within study groups
3.748
63
0.059

Total
262.372
69

Analysis of variance revealed a statistical significance in the mean AgNOR count among different groups ().

Table 3 shows the intergroup comparison between the different study groups.

Table 3: Intergroup comparison.

Group
Mean ± S.D.
Statistical significance

Group I
2.572 ± 0.121
NOM versus ED: ;

Group III
5.602 ± 0.456
NOM versus OSCC: ;

Group III
8.073 ± 0.655
ED versus OSCC: ;

Intergroup comparison revealed statistically significant difference between different study groups specifying that it was possible to differentiate different diagnostic groups with the help of mean AgNOR count. The order of mean AgNOR count in relation to the diagnostic groups was as follows.

NOM < mild ED < moderate ED < severe ED < well differentiated OSCC < moderately differentiated OSCC < poorly differentiated OSCC.

4. Discussion

Leukoplakia is a predominantly white lesion of the oral mucosa that cannot be characterized as any other definable lesion [5]. It is a clinical term and it is recommended that a histological report should always include a statement on the presence or absence of ED, along with assessment of its severity [6]. ED is more or less correlating with a clinical nonhomogeneous erythroleukoplakic subtype, which seems to be the most important indicator of malignant potential [7].

OSCC is a malignant neoplasm of oral mucosal epithelium. Reference [8] is the sixth most common malignancy and a major cause of cancer morbidity and mortality worldwide [9]. It is recognized as a disease resulting from genetic damage, leading to uncontrolled cell proliferation of damaged cells [8]. Oral cancer patients share the common high risk of developing multiple or sequential primary carcinomas within the upper aerodigestive tract due to field cancerization. Early detection of premalignant and/or neoplastic lesions is therefore crucial for improving the long-term prospective of patients suffering from OSCC. To date, no clear markers for distinguishing mild, moderate, and severe ED have evolved and histological criteria for diagnosing a “dysplastic” lesion are still subjective [2].

NOR are loops of DNA on the short arms of acrocentric chromosomes that presumably are associated with ribosomal RNA activity, protein synthesis, and cell proliferations. The patterns of neither NOR by size and distribution, as visualized by silver staining (AgNOR), are known to vary with different cell cycle stages. The number of AgNOR increases from the early G1 phase to late S/G₂ phases. The number of AgNOR at any given stage in the cell cycle appears to be inversely proportional to the cell cycle time, that is, the higher the amount of AgNOR, the shorter the cell cycle time [3]. AgNOR have been shown to be replicatory markers. Mean AgNOR count can be useful in diagnosing histological features representing oral leukoplakia and has been shown to correlate with clinical outcomes of various cancers [10]. An obvious feature of all oral cancers is excessive proliferation of oral keratinocytes. Initially keratinocyte proliferation may be confined to the epithelial compartment resulting in a thickened and disorganized epithelium. Individual keratinocytes show nuclear hyperchromatism (dark staining), nuclear pleomorphism (abnormal shape), enlarged nucleoli, increased nuclear: cytoplasmic ratio, increased mitoses, atypical mitoses, and multinucleation [11]. Even though H&E staining is routinely used for diagnosing carcinoma histologically, in some instances, histopathological features are not defined sufficiently to determine the true nature of these disturbances. Thus, alternative methods like silver colloid technique for staining NOR in nucleus are a helpful histochemical technique to provide more information about the cellular status [12].

Several studies have demonstrated that AgNOR being replicatory markers may be useful in diagnosis of various neoplasms. OSCC can be distinguished from normal epithelium by AgNOR count. Furthermore, some studies observed that it might be possible to use AgNOR to distinguish mild and moderate ED. AgNOR technique, being inexpensive and its results easily reproducible, can be very effective in resource-poor setting [2].

NORs were first detected on Giemsa banding as “achromatic gaps” with much reduced staining. The areas are not, of course, genuine gaps but are areas of specialized chromosomal configuration. The major advance in the demonstration of NOR came with the discovery that they are highly argyrophilic, because of the properties of some of their associated proteins. Accordingly, one of the most popular methods for demonstrating these areas has made use of the binding of Ag+ ions and the structures revealed have been assigned the rather unattractive name AgNOR. It was shown, then, that the achromatic gap areas on the acrocentric chromosomes were argyrophilic and the silver binding method became a standard. It was found repeatedly that the numbers of histochemically stained NOR in interphase cells represented their proliferative state rather than any other variable, such as, for example, protein synthetic level [13].

The quantification of these has been a useful method in diagnostic pathology especially in the differential diagnosis between benign and malignant tumors and helpful in recognizing limitrophic lesions [12].

Our study was carried out to determine and compare mean AgNOR counts in normal oral mucosa and oral leukoplakia with ED and OSCC. Comparison was also done between different degrees of ED in oral leukoplakia group and different stages of OSCC.

Gomez suggested that AgNOR can be useful as a compliment to histopathological examination and to a certain point indicates degree of malignant/dysplastic alterations [14].

The results of the present study showed an increase in mean AgNOR count in both oral leukoplakia with ED and OSCC over NOM. AgNOR in OSCC were smaller, more numerous, and more scattered throughout the nuclei than in the normal epithelium. Leukoplakia with ED also showed smaller and more scattered dots. These results were in accordance with the study conducted by Chattopadhyay [15]. The higher AgNOR counts and smaller more widely scattered dots in dysplastic leukoplakia appear to be a significant finding. It suggests that as the lesion becomes more dysplastic and ultimately malignant, the AgNOR count tends to increase and AgNOR dot size decreases as the dots are more widely scattered over the nuclei. According to Chattopadhyay the AgNOR pattern suggests strong correlation of AgNOR character with cell replicatory capacity and cellular differentiation. The highly replicatory areas of basal cell hyperplasia have shown high count, high scatter, and smaller AgNOR, factors which reverse in the nonreplicatory higher layers where cellular differentiation becomes more evident [16].

The results of this study revealed mean AgNOR counts in oral leukoplakia with ED to be higher than in the control group () (Figure 1). It correlates with the findings of Chattopadhyay [15].

Figure 1: AgNOR dots seen in mild epithelial dysplasia under oil immersion lens (100x).

Ray et al. in their studies on premalignant lesions showed higher mean AgNOR counts in leukoplakia as compared to normal epithelium, [10] which was similar to our study which showed increase in mean AgNOR counts from mild to severe epithelial dysplasia in various leukoplakic lesions. Warnakulasuriya and Johnson also revealed more dispersed counts of AgNOR in all types of dysplasias. [17].

In the present study, out of ten cases of mild, moderate, and severe dysplasia, the mean AgNOR counts were 5.184, 5.628, and 5.993, respectively. This indicated that the higher the proliferative activity of cells, the greater the grade of dysplasia with increase in the AgNOR counts. In accordance with the present study, Xie et al. showed significant differences of mean AgNOR counts between normal epithelium and mild and severe dysplasia [3]. Study of Pandit and Aithal also revealed the same [18].

The findings of our study showed AgNOR counts to be much higher in OSCC, when compared to oral leukoplakia with ED (Figure 2). Similarly in our study there has been a progressive increase in the values of total AgNOR from mild to moderate to severe ED. Chattopadhyay et al. stated that AgNOR counts can be a useful parameter to determine the presence of dysplasia. With respect to mean AgNOR counts, leukoplakia occupies a distribution between that of normal epithelium and squamous cell carcinoma [19]. The AgNOR technique therefore seems to be a strong potential candidate for a test that could provide objective criteria for marking dysplasia. Kahn et al. also revealed that the average maximum AgNOR count shows a tendency to increase with each increasing grade of dysplasia [20]. Similar findings were reported by Cabrini et al. and Chattopadhyay who showed that the number of AgNOR per nucleus increased from normal oral mucosa to squamous cell carcinoma [15, 21].

Figure 2: AgNOR dots seen in poorly differentiated oral squamous cell carcinoma under oil immersion lens (100x).

5. Conclusion

Mean AgNOR counts allow discrimination between NOM, oral leukoplakia with ED, and well differentiated OSCC. Higher values in severe ED may suggest a greater risk of malignant transformation.

AgNOR counting had a significant correlation between normal and malignant epithelium and with stage of disease. High AgNOR expression has poorer prognostic indication than lower AgNOR values.

An association between cell proliferation and AgNOR counting in OSCC indicates that quantitative analysis of the mean number of NORs per nucleus represents a useful and inexpensive method for measuring cell proliferation in OSCC. Routine use of AgNOR stain in dysplastic lesions and early OSCC helpful for unequivocal diagnosis of these lesions which otherwise remained highly subjective in nature.

Further studies are warranted to quantify AgNOR probably in the invasive tumor front especially in the OSCC as the prognostic relevance of invasive tumor front has been established in classical histopathological studies. The findings of such studies could be of immense help in correlating the clinical course of the disease and may throw light into overall survival and disease-free survival over a period of time.

Conflict of Interests

The authors declare there is no conflict of interests regarding of publication of this paper.

Authors’ Contribution

Fahad Mansoor Samadi, Bastain Thattil Sebastian, and Anil Singh were responsible for the design. Shaleen Chandra, Shadab Mohammad, and Arun Singh collated the Information. Thippeswamy Halappa wrote the initial version of the paper, which was modified and edited by Firoza Samadi.

References

C. Scully, “Oral precancer: preventive and medical approaches to management,” European Journal of Cancer B: Oral Oncology, vol. 31, no. 1, pp. 16–26, 1995.

A. Chattopadhyay and J. G. Ray, “AgNOR cut-point to distinguish mild and moderate epithelial dysplasia,” Journal of Oral Pathology and Medicine, vol. 37, no. 2, pp. 78–82, 2008.

X. Xie, O. P. F. Clausen, J. Sudbo, and M. Boysen Epithelium, “Diagnostic and prognostic value of nucleolar organizer regions in normal dysplasia, and squamous cell carcinoma of the oral cavity,” Cancer, vol. 79, pp. 2200–2208, 1997.

R. Smith and J. Crocker, “Evaluation of nucleolar organizer region-associated proteins in breast malignancy,” Histopathology, vol. 12, no. 2, pp. 113–125, 1988.

S. Warnakulasuriya, N. W. Johnson, and I. van der Waal, “Nomenclature and classification of potentially malignant disorders of the oral mucosa,” Journal of Oral Pathology and Medicine, vol. 36, no. 10, pp. 575–580, 2007.

R. Rajendran and B. Sivapathasundharam, Shafer’s Textbook of Oral Pathology, Elsevier, New Delhi, India, 5th edition, 2007.

M. Pandey, G. Thomas, T. Somanathan et al., “Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India,” Oral Oncology, vol. 37, no. 1, pp. 103–109, 2001.

S. Jefferies and W. D. Foulkes, “Genetic mechanisms in squamous cell carcinoma of the head and neck,” Oral Oncology, vol. 37, no. 2, pp. 115–126, 2001.

J. K. Nagpal and B. R. Das, “Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management,” Oral Oncology, vol. 39, no. 3, pp. 213–221, 2003.

J. G. Ray, A. Chattopadhyay, and D. J. Caplan, “Usefulness of AgNOR counts in diagnosing epithelial dysplasia,” Journal of Oral Pathology and Medicine, vol. 32, no. 2, pp. 71–76, 2003.

P. B. Sugerman and N. W. Savage, “Current concepts in oral cancer,” Australian Dental Journal, vol. 44, no. 3, pp. 147–156, 1999.

L. M. Fonseca and M. A. Do Carmo, “AgNORs in hyperplasia, papilloma and oral squamous cell carcinoma,” Brazilian Dental Journal, vol. 11, no. 2, pp. 105–110, 2000.

J. Crocker, “Molecular and biochemical aspects of interphase nucleolar organiser regions,” Journal of Clinical Pathology—Clinical Molecular Pathology, vol. 49, no. 1, pp. M8–M11, 1996.

G. J. A. Gomez, “Analysis of the tissue marker AgNOR in leukoplakia and oral squamous cell carcinoma,” Medicina Oral, vol. 7, pp. 17–25, 2002.

A. Chattopadhyay, “Silver-binding nucleolar organizing regions: a study of oral leukoplakia and squamous cell carcinoma,” International Journal of Oral and Maxillofacial Surgery, vol. 23, no. 6, pp. 374–377, 1994.

A. Chattopadhyay, “AgNORs in tumoral pathology. Review of literature and observations on the technic and reaction in normal oral epithelium,” Indian Journal of Dental Research, vol. 4, no. 2, pp. 47–53, 1993.

K. A. A. S. Warnakulasuriya and N. W. Johnson, “Nucleolar organiser region (NOR) distribution as a diagnostic marker in oral keratosis, dysplasia and squamous cell carcinoma,” Journal of Oral Pathology and Medicine, vol. 22, no. 2, pp. 77–81, 1993.

S. Pandit and D. Aithal, “A qualitative and quantitative estimation of AgNORS in dysplastic and non-dysplastic leukoplakias,” Indian Journal of Dental Research, vol. 13, no. 1, pp. 27–30, 2002.

A. Chattopadhyay, J. G. Ray, and D. J. Caplan, “AgNOR count as objective marker for dysplastic features in oral leukoplakia,” Journal of Oral Pathology and Medicine, vol. 31, no. 9, pp. 512–517, 2002.

M. A. Kahn, H. H. Mincer, M. E. Dockter, and J. M. Hermann-Petrin, “Comparing flow cytometric analysis and nucleolar organizer region enumeration in archival oral premalignant lesions,” Journal of Oral Pathology and Medicine, vol. 22, no. 6, pp. 257–262, 1993.

R. L. Cabrini, A. E. Schwint, A. Mendez, F. Femopase, H. Lanfranchi, and M. E. Itoiz, “Morphometric study of nucleolar organizer regions in human oral normal mucosa, papilloma and squamous cell carcinoma,” Journal of Oral Pathology and Medicine, vol. 21, no. 6, pp. 275–279, 1992.